Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Feb;51(2):401–406.

Antibodies to large glycopeptides in sera from patients with ovarian germ cell tumours.

M Kawata, K Higaki, S Sekiya, H Takamizawa, T Muramatsu, K Okumura
PMCID: PMC1536897  PMID: 6301713

Abstract

Antibodies reactive with a murine teratocarcinoma cell line (F9) were detected by immunofluorescence staining in sera from patients bearing ovarian germ cell tumour. Immunochemical studies revealed that antibodies binding to the cell surface of F9 cells react with large glycopeptides which are known to be components of F9 antigens defined by murine anti-F9 antibodies. In addition, treatment of F9 cells with retinoic acid, which induces differentiation of embryonal carcinoma cells, distinctly reduced both the ability of these antibodies to stain F9 cells and the biosynthesis of large glycopeptides by the cells. These findings indicate that the large glycopeptides precipitable by the patients' antibodies are differentiation associated antigens on characteristic embryonic cells.

Full text

PDF
401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. W., Bronson D. L., Benham F., Strickland S., Knowles B. B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer. 1980 Sep 15;26(3):269–280. doi: 10.1002/ijc.2910260304. [DOI] [PubMed] [Google Scholar]
  2. Gooi H. C., Feizi T., Kapadia A., Knowles B. B., Solter D., Evans M. J. Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature. 1981 Jul 9;292(5819):156–158. doi: 10.1038/292156a0. [DOI] [PubMed] [Google Scholar]
  3. Hogan B., Fellous M., Avner P., Jacob F. Isolation of a human teratoma cell line which expresses F9 antigen. Nature. 1977 Dec 8;270(5637):515–518. doi: 10.1038/270515a0. [DOI] [PubMed] [Google Scholar]
  4. Holden S., Bernard O., Artzt K., Whitmore W. F., Jr, Bennett D. Human and mouse embryonal carcinoma cells in culture share an embryonic antigen (F9). Nature. 1977 Dec 8;270(5637):518–520. doi: 10.1038/270518a0. [DOI] [PubMed] [Google Scholar]
  5. Kapadia A., Feizi T., Evans M. J. Changes in the expression and polarization of blood group I and i antigens in post-implantation embryos and teratocarcinomas of mouse associated with cell differentiation. Exp Cell Res. 1981 Jan;131(1):185–195. doi: 10.1016/0014-4827(81)90418-3. [DOI] [PubMed] [Google Scholar]
  6. Muramatsu H., Muramatsu T. Decreased synthesis of large fucosyl glycopeptides during differentiation of embryonal carcinoma cells induced by retinoic acid and dibutyryl cyclic AMP. Dev Biol. 1982 Apr;90(2):441–444. doi: 10.1016/0012-1606(82)90394-3. [DOI] [PubMed] [Google Scholar]
  7. Muramatsu T., Avner P., Fellous M., Gachelin G., Jacob F. Distinctive properties of fucosyl glycopeptides on human teratoma cells. Somatic Cell Genet. 1979 Nov;5(6):753–761. doi: 10.1007/BF01542639. [DOI] [PubMed] [Google Scholar]
  8. Muramatsu T., Condamine H., Gachelin G., Jacob F. Changes in fucosyl-glycopeptides during early post-implantation embryogenesis in the mouse. J Embryol Exp Morphol. 1980 Jun;57:25–36. [PubMed] [Google Scholar]
  9. Muramatsu T., Gachelin G., Jacob F. Characterization of glycopeptides isolated from membranes of F9 embryonal carcinoma cells. Biochim Biophys Acta. 1979 Oct 18;587(3):392–406. doi: 10.1016/0304-4165(79)90443-4. [DOI] [PubMed] [Google Scholar]
  10. Muramatsu T., Gachelin G., Nicolas J. F., Condamine H., Jakob H., Jacob F. Carbohydrate structure and cell differentitation: unique properties of fucosyl-glycopeptides isolated from embryonal carcinoma cells. Proc Natl Acad Sci U S A. 1978 May;75(5):2315–2319. doi: 10.1073/pnas.75.5.2315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Prujansky-Jacobovits A., Gachelin G., Muramatsu T., Sharon N., Jacob F. Surface galactosyl glycopeptides of embryonal carcinoma cells. Biochem Biophys Res Commun. 1979 Jul 27;89(2):448–455. doi: 10.1016/0006-291x(79)90650-8. [DOI] [PubMed] [Google Scholar]
  12. Solter D., Knowles B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978 Nov;75(11):5565–5569. doi: 10.1073/pnas.75.11.5565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stern P. L., Willison K. R., Lennox E., Galfrè G., Milstein C., Secher D., Ziegler A. Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell. 1978 Aug;14(4):775–783. doi: 10.1016/0092-8674(78)90333-1. [DOI] [PubMed] [Google Scholar]
  14. Zeuthen J., Nørgaard J. O., Avner P., Fellous M., Wartiovaara J., Vaheri A., Rosén A., Giovanella B. C. Characterization of a human ovarian teratocarcinoma-derived cell line. Int J Cancer. 1980 Jan 15;25(1):19–32. doi: 10.1002/ijc.2910250104. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES